138 related articles for article (PubMed ID: 30608334)
1. A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II-Induced Pressure Response in Mice.
Nishi M; Yonesu K; Tagawa H; Kato M; Marumoto S; Nagayama T
J Cardiovasc Pharmacol; 2019 Jan; 73(1):15-21. PubMed ID: 30608334
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
[TBL] [Abstract][Full Text] [Related]
3. The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure.
Nishi M; Tagawa H; Ueno M; Marumoto S; Nagayama T
Heliyon; 2020 Feb; 6(2):e03352. PubMed ID: 32055741
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.
Clozel M; Binkert C; Birker-Robaczewska M; Boukhadra C; Ding SS; Fischli W; Hess P; Mathys B; Morrison K; Müller C; Müller C; Nayler O; Qiu C; Rey M; Scherz MW; Velker J; Weller T; Xi JF; Ziltener P
J Pharmacol Exp Ther; 2004 Oct; 311(1):204-12. PubMed ID: 15146030
[TBL] [Abstract][Full Text] [Related]
5. Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity.
Song W; McDonald J; Camarda V; Calo G; Guerrini R; Marzola E; Thompson JP; Rowbotham DJ; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):148-57. PubMed ID: 16596397
[TBL] [Abstract][Full Text] [Related]
6. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
8. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.
Rossowski WJ; Cheng BL; Taylor JE; Datta R; Coy DH
Eur J Pharmacol; 2002 Mar; 438(3):159-70. PubMed ID: 11909607
[TBL] [Abstract][Full Text] [Related]
9. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
10. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.
Gendron G; Simard B; Gobeil F; Sirois P; D'Orléans-Juste P; Regoli D
Can J Physiol Pharmacol; 2004 Jan; 82(1):16-21. PubMed ID: 15052301
[TBL] [Abstract][Full Text] [Related]
11. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
Douglas SA; Sulpizio AC; Piercy V; Sarau HM; Ames RS; Aiyar NV; Ohlstein EH; Willette RN
Br J Pharmacol; 2000 Dec; 131(7):1262-74. PubMed ID: 11090097
[TBL] [Abstract][Full Text] [Related]
12. Ligands and signaling of the G-protein-coupled receptor GPR14, expressed in human kidney cells.
Lehner U; Velić A; Schroter R; Schlatter E; Sindić A
Cell Physiol Biochem; 2007; 20(1-4):181-92. PubMed ID: 17595527
[TBL] [Abstract][Full Text] [Related]
13. Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.
Zhao J; Zhang SF; Shi Y; Ren LQ
Bosn J Basic Med Sci; 2013 May; 13(2):78-83. PubMed ID: 23725502
[TBL] [Abstract][Full Text] [Related]
14. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
[TBL] [Abstract][Full Text] [Related]
15. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
Chatenet D; Létourneau M; Nguyen QT; Doan ND; Dupuis J; Fournier A
Br J Pharmacol; 2013 Feb; 168(4):807-21. PubMed ID: 22994258
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.
Ziltener P; Mueller C; Haenig B; Scherz MW; Nayler O
J Recept Signal Transduct Res; 2002; 22(1-4):155-68. PubMed ID: 12503613
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist.
Behm DJ; Herold CL; Ohlstein EH; Knight SD; Dhanak D; Douglas SA
Br J Pharmacol; 2002 Oct; 137(4):449-58. PubMed ID: 12359626
[TBL] [Abstract][Full Text] [Related]
19. Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate.
Douglas SA; Ashton DJ; Sauermelch CF; Coatney RW; Ohlstein DH; Ruffolo MR; Ohlstein EH; Aiyar NV; Willette RN
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S163-6. PubMed ID: 11078367
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.
Gong H; Wang YX; Zhu YZ; Wang WW; Wang MJ; Yao T; Zhu YC
J Appl Physiol (1985); 2004 Dec; 97(6):2228-35. PubMed ID: 15273242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
